Navigation Links
Medco Tops Fortune's List of 'America's Most Admired' Companies in its Industry
Date:3/6/2008

Medco listed No. 1 Among Health Care: Pharmacy and Other Services; No. 1 in People Management; Runner-up to Berkshire-Hathaway as Long-Term Investment;

No. 3 for Innovation

FRANKLIN LAKES, N.J., March 6 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS), captured the No. 1 position within the Health Care: Pharmacy and Other Services sector on Fortune's America's Most Admired Companies List. In addition, of all companies surveyed, Medco was ranked No. 1 in People Management. Medco was listed as No. 2 among all companies as "Most Admired: Long-Term Investment" -- second only to Berkshire Hathaway; and third in the U.S. based on "Innovation," trailing Apple and Nike.

"To be ranked highest among our industry peers is a tremendous honor. To join some of the world's most revered companies across all industries -- second only to the legendary Berkshire Hathaway as a quality investment and in the same league as Apple and Nike for innovation -- underscores the value Medco delivers to the marketplace in improving clinical and financial outcomes for the millions of Americans we serve every day," said David B. Snow Jr., Medco Chairman and CEO.

Fortune, in partnership with the Hay Group, surveyed 622 companies across 64 industry sectors. To create the industry lists, executives, directors and analysts were asked to rate companies in their own industry on eight criteria, from investment value to social responsibility. Results are featured in the March 17th issue of Fortune magazine.

According to the Fortune survey, Medco received several industry and national honors:
-- No. 1 Most-Admired: "Health Care: Pharmacy and Other Services"

category -- with the industry's h
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System
2. Medco Full-Year and Fourth-Quarter Earnings Results Exceed High End of Company Expectations
3. Medco Launches Medicare Part D Initiative to Promote ePrescribing
4. Medco Announces Date for Fourth-Quarter and Full-Year 2007 Financial Results
5. Medcos Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation
6. Medco CEO Reiterates Guidance, Positive Outlook for 2008
7. MedcomSoft Receives 2007s "Best in KLAS" EMR Ranking (1-5 Physicians)
8. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
9. URAC Names Medco as a Finalist in First-ever Best Practices in Consumer Empowerment and Protection Awards
10. Medco Announces Two-For-One Stock Split
11. Medco CEO to Present at the Merrill Lynch & Co., Inc. 2007 Health Services Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...team develops device giving patients freedom of mo...DAY, July 26 (HealthDay News) -- An automated arti...e day be to dialysis patients what the insulin pum...rable artificial kidney (AWAK) works better than c...current issue of Clinical and Experimental Nephro...
(Date:7/25/2008)...AKE SUCCESS, N.Y., July 25 /PRNewswire-USNewswire/...as Chief Quality Officer and Vice President,of Str...monwealth Fund, a,national foundation committed to...e directed the foundation,s Program on Health Care...p://www.newscom.com/cgi-bin/prnh/20080725/DC28791L...
(Date:7/25/2008)...red immune response after antiretroviral therapy m... July 25 (HealthDay News) -- A new study challenge...(HCV) impairs the immune system,s ability to resto...ly active antiretroviral therapy (HAART). , Fro...ers are also infected with HCV. Intravenous drug u...
(Date:7/25/2008)...he Authority offers patients consumers tips and en...ient safety, HARRISBURG, Pa., July 25 /PRNewswire...thority today supports "National Patient Safety Da...s and their families to,participate fully in their...thing they can about their surgery or illness., "...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...eloped a three-dimensional image of the AIDS virus...h aids in fusing// with human immune cells – An ex...agnosed. Findings from this AIDS research could ...ill thwart infection by targeting and crippling th...
... highly conducive for the cognitive development of...d//. Infact, even moderated alcohol intake during ... the unborn child. The study conducted by the Univ...ne and the University of Washington, has shown tha...
...the administration in WHO, to an agreement that wi...ent//. This is indeed a quantum leap in this field...ed. Moreover, it will also infuse renewed thrust i...h will in turn pave the way for novel methods to s...
...ing world statistics regarding the use of tobacco ...st one in five 13-15 year olds consume tobacco and...in the run up to the World Health Organization's W... years theme will revolve around the topic, ''toba...
Other Medicine News:Health News:Three-Dimensional Image Of AIDS Virus – BY FSU Researcher 2Health News:Three-Dimensional Image Of AIDS Virus – BY FSU Researcher 3
(Date:7/24/2008)...a Support Prognostic Value of Circulating Tumor Ce...ternational, prospective,clinical trial found the ...ng indicator of progression-free and overall survi...ccording to a report published in the July 1,issue... conducted in the US, the Netherlands, and the Uni...
(Date:7/24/2008)...HINGTON, July 24 /PRNewswire-USNewswire/ -- Headli...ot tell the whole story. The small scale,prelimin...e in Human,Reproduction, is based on recollected i...ning soyfoods. "This study is confounded by many,i...th a great deal of,caution," warned Dr. Tammy Hedl...
(Date:7/23/2008)...exavar is First Approved Systemic Therapy to Treat...., July 23 /-,Bayer HealthC... (Nasdaq:,ONXX) today announced that The New Engla...e 3 trial demonstrating that Nexavar(R) (sorafenib...31 percent in patients with,unresectable hepatocel...
(Date:7/23/2008)...S Study Finds Some Areas of the Body Have Greater ...Ill., July 23 /PRNewswire-USNewswire/ -- Fat remov...liposuction was found to be,an excellent source of...than other areas of the body, reports a Brazilian-... Surgery(R), the official medical journal of the,A...
Breaking Medicine Technology:Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 2Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer 3Soyfoods Do Not Impact Sperm Count 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Nurses Doctors Patients to Protest Health Insurers at National Day of Action June 19th 21840 1Nurses Doctors Patients to Protest Health Insurers at National Day of Action June 19th 21840 2Alexion to Present at the William Blair 28th Annual Growth Stock Conference 5985 1How to Have Your Tomatoes and Eat Them Too 21838 1How to Have Your Tomatoes and Eat Them Too 21838 2How to Have Your Tomatoes and Eat Them Too 21838 3Emory study of syphilis bacteria yields valuable diagnostic tool 21836 1Emory study of syphilis bacteria yields valuable diagnostic tool 21836 2
Merocel Ophthalmic Products provide the surgeon with superior fiber free products for unparalleled fluid control and safe cleaning of fine microsurgical instruments. The exclusive Merocel material is
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box.
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box.
The Wet-Field Coagulator provides precise episcleral, intrascleral, and intraocular hemostasis with reduced peripheral tissue trauma. Controlled Rf diathermy delivers targeted coagulation with the mo
Medicine Products: